[Comment] Compara tive effectiveness of bevacizumab versus cetuximab in meta static colorectal cancer patients without primary tumor resec tion
Primary tumor resection may be unfeasible in metastatic colorectal cancer. We determined the effects of bevacizumab and cetuximab therapies on survival or conversion surgery in patients with metastatic colorectal cancer who did not undergo primary tumor resection. This retrospective cohort study enr...
Saved in:
| Main Authors: | Li Yingru, Li Shaotang |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Colorectal & Anal Surgery
2022-08-01
|
| Series: | 结直肠肛门外科 |
| Online Access: | https://jcas.gxmuyfy.cn/cn/wqll/paper.html?id=390&cateName=2022%E5%B9%B4%20%E7%AC%AC28%E5%8D%B7%20%E7%AC%AC4%E6%9C%9F |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[Comment] Long term oncologic outcomes of natural orifice specimen extrac tion surgery versus conventional laparoscopic-assisted resec tion in the treatment of rectal cancer: a propensity-score matching study
by: Wang Tao
Published: (2022-10-01) -
A compara tive analysis of short-term patient outcomes after laparoscop ic versus robotic rectal surgery
by: Chi Zhaocheng
Published: (2022-04-01) -
WALTER GOLDSCHMIDT. Comparaive functionalism
by: Claudio Esteva faregat
Published: (2010-05-01) -
[Comment] Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older pa tients with RAS wild-type metastatic colorectal cancer:an analysis of the randomised trial FIRE-3
by: Wu Deqing
Published: (2022-08-01) -
[Comment] Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): a randomized controlled trial
by: Zhang Rongxin
Published: (2024-08-01)